New Trends in Brain Shuttle Peptides

Year: 2025 Authors: Roger Prades, Meritxell Teixidó,  Benjamí Oller Salvia Journal:  ACS Publications Abstract The…

A Site-Specific MiniAp4−Trastuzumab Conjugate Prevents Brain Metastasis

Year: 2025 Authors: Mariam Masmudi-Martín, María Perea, Meritxell Teixidó, Manuel Valiente, Ernest…

Amphiphilic Polymeric Nanoparticles Modified with Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma

Year: 2021 Authors: Alexandra Bukchin, Macarena Sanchez-Navarro, Adam Carrera, Claudia Resa-Pares, Helena…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social